Outcomes and Risk Factors Associated with Drug Resistant Tuberculosis in Rural Eastern Cape, South Africa

被引:2
|
作者
Fotso, Carine Bokop
Vasaikar, Sandeep D.
Apalata, Teke [1 ]
机构
[1] Walter Sisulu Univ, Fac Hlth Sci, Dept Lab Med & Pathol, Div Med Microbiol, Mthatha, South Africa
关键词
Multidrug-Resistant; Extensively Drug-Resistant; Outcomes; Risk Factors; Favourable Outcomes; Poor Outcomes;
D O I
10.3844/ajidsp.2018.69.76
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
With the emergence of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) strains of Mycobacterium tuberculosis, Tuberculosis (TB) has become an even greater threat in South Africa (SA). The study sought to investigate the resistance pattern of anti-TB drugs in M. tuberculosis as well as to determine the associated risk factors and outcomes for MDR-TB and XDR-TB. A descriptive study was conducted in 2 sub-districts of Eastern Cape province. Laboratory testing on sputum samples was done using genotypic and phenotypic methods. Data related to risk factors and outcomes were collected. SPSS v. 22 was used for statistical analyses. 224 patients were enrolled (33.9% HIV negative and 66.1% HIV positive). Of 224 TB isolates obtained, 196 (87.5%) were MDR-TB (including 23 rifampicin mono-resistant isolates), 2 (0.9%) were isoniazid mono-resistant and 26 (11.6%) were Pre-XDR and XDR-TB. Of 196 MDR-TB patients, 143 (72.9%) had a favourable outcome post anti-TB therapy as compared to 17(65.4%) XDR-TB patients out of 26; but this difference was not statistically significant (OR = 1.5; CI: 0.6 - 3.4; rho = 0.27). Whilst 118 (68.6%) out of 172 MDR-TB cases were newly diagnosed, previous exposure to anti-TB therapy was found to be a significant risk factor for developing XDR-TB (OR = 2.5; CI = 1.1 - 5.9; rho = 0.023). Despite that 34 (26.2%) out of 130 new drug-resistant (DR)-TB patients completed their therapy, only 17 (13.1%) were declared cured as compared to 23 (33.8%) cured patients among the previously treated group (rho < 0.0001). In contrary, 9 (13.2%) cases of relapse and 11 (16.2%) defaulters were found among the previously treated DR-TB patients as compared to new cases [1 (0.8%) relapse versus 11 (8.5%) defaulters, respectively] on therapy (rho < 0.0001). High rates of DR-TB among treatmentnaive patients, compounded with prevalent cases of relapses and defaulters among previously treated patients, raise the importance of DR-TB acquisition through direct transmission rather than the evolution of resistance.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 50 条
  • [1] Spatial Distribution of Drug-Resistant Mycobacterium tuberculosis Infections in Rural Eastern Cape Province of South Africa
    Faye, Lindiwe M.
    Hosu, Mojisola C.
    Vasaikar, Sandeep
    Dippenaar, Anzaan
    Oostvogels, Selien
    Warren, Rob M.
    Apalata, Teke
    [J]. PATHOGENS, 2023, 12 (03):
  • [2] Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa
    Elliott, E.
    Draper, H. R.
    Baitsiwe, P.
    Claassens, M. M.
    [J]. PUBLIC HEALTH ACTION, 2014, 4 (03): : 201 - 203
  • [3] Kidney damage and associated risk factors in the rural Eastern Cape, South Africa: A cross-sectional study
    Gonzalez, Ernesto Rosales
    Yogeswaran, Parimalanie
    Chandia, Jimmy
    Estrada, Guillermo Alfredo Pulido
    Adeniyi, Oladele Vincent
    [J]. PLOS ONE, 2024, 19 (09):
  • [4] Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
    Kvasnovsky, Charlotte L.
    Cegielski, J. Peter
    van der Walt, Martie L.
    [J]. EMERGING INFECTIOUS DISEASES, 2016, 22 (09) : 1529 - 1536
  • [5] The Effect of HIV and Antiretroviral Therapy on Drug-Resistant Tuberculosis Treatment Outcomes in Eastern Cape, South Africa: A Cohort Study
    van de Water, Brittney
    Abuelezam, Nadia
    Hotchkiss, Jenny
    Botha, Mandla
    Ramangeola, Limpho
    [J]. VIRUSES-BASEL, 2023, 15 (11):
  • [6] Risk factors for catastrophic costs associated with tuberculosis in rural South Africa
    Strecker, N.
    Hanrahan, C.
    Mmolawa, L.
    Nonyane, B.
    Tempi, R.
    Tucker, A.
    West, N.
    Lebina, L.
    Martinson, N.
    Dowdy, D.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (06) : 756 - 763
  • [7] Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013
    Chingonzoh, Ruvimbo
    Manesen, Mohamed R.
    Madlavu, Mncedisi J.
    Sopiseka, Nokuthula
    Nokwe, Miyakazi
    Emwerem, Martin
    Musekiwa, Alfred
    Kuonza, Lazarus R.
    [J]. PLOS ONE, 2018, 13 (08):
  • [8] Clonality and genetic profiles of drug-resistant Mycobacterium tuberculosis in the Eastern Cape Province, South Africa
    Bhembe, Nolwazi L.
    Nwodo, Uchechukwu U.
    Okoh, Anthony, I
    Obi, Chikwelu L.
    Mabinya, Leonard, V
    Green, Ezekiel
    [J]. MICROBIOLOGYOPEN, 2019, 8 (03):
  • [9] Diabetes knowledge and associated factors in rural Eastern Cape, South Africa: A cross sectional study
    Owolabi, Eyitayo Omolara
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S26 - S26
  • [10] Knowledge of diabetes and associated factors in rural Eastern Cape, South Africa: A cross sectional study
    Owolabi, Eyitayo Omolara
    Goon, Daniel Ter
    Ajayi, Anthony Idowu
    Adeniyi, Oladele Vincent
    [J]. PLOS ONE, 2022, 17 (07):